Nanoparticle-based drug delivery systems.

Nanoparticle-based drug delivery systems have emerged as one of the most promising strategies in modern medicine, offering innovative solutions to overcome the limitations of conventional therapies. Their nanoscale dimensions enable improved interactions with biological systems, allowing drugs to be protected from degradation, enhancing their solubility and bioavailability, and enabling controlled and sustained release. As a result, nanoparticles can increase therapeutic efficacy while reducing systemic toxicity and unwanted side effects. Depending on their composition and design, they can also facilitate the delivery of a wide range of therapeutic agents, including small molecules, proteins, peptides, and nucleic acids.

​

To further improve localized therapies, nanoparticles can be incorporated into hydrogel matrices, creating multifunctional delivery platforms that combine the advantages of both systems. These hybrid formulations provide sustained drug release, improve nanoparticle retention at the administration site, protect encapsulated therapeutics, and enhance treatment efficacy. 

​​

The performance of nanocarriers can be further enhanced through surface functionalization. By modifying their surface with polymers, peptides, antibodies, or other targeting ligands, nanoparticles can selectively recognize specific cells or tissues, improve cellular uptake, prolong circulation time, and overcome biological barriers such as the blood–brain barrier. Surface engineering also enables the development of multifunctional nanoplatforms capable of combining targeted therapy with diagnostic or imaging capabilities.

​

​

​​Our Nanoplatforms and Their Applications

At Nano4Med, we develop and characterize a broad range of nanocarriers for different biomedical applications. Our expertise includes:

• Liposomes

• Solid lipid nanoparticles

• Nanostructured lipid carriers

• PLGA nanoparticles

• Lipid-polymer hybrid nanoparticles

• Carbohydrate nanoparticles

• Polysaccharide nanoparticles

• Gold nanoparticles

• ​Iron oxide nanoparticles

​

Our research focuses on translating nanotechnology into innovative healthcare solutions. We develop nanoparticle-based platforms for:

• Cancer (glioblastoma multiforme)

• Neurodegenerative diseases (Alzheimer's disease and Parkinson's disease)

• Cosmetic application